Scholars Central

Conference abstractPublished 27 Sep 2018

Cellular and molecular mechanisms of impaired angiogenesis and delayed wound healing in type 2 diabetes: Amelioration using siRNA-Pluronic acid-based technology

Authors: Milad S. Bitar

Kuwait University, Kuwait

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Angiogenesis, de novo capillary outgrowth from pre-existing vascular network, is crucial for wound healing and involves endothelial loosening, endothelial cell migration, stalk elongation, anastomosis and stabilization. This process is initiated and sustained until the terminal stage of healing and is orchestrated by a variety of growth factors/cytokines with vascular endothelial growth factor (VEGF) being the predominant regulator. Insufficient angiogenesis and non-functional vasculature are common features of non-healing diabetic wounds. This phenomenon may stem from an imbalance between pro-angiogenic (e.g., VEGF) and anti-angiogenic (e.g., thrombospondins) mediators with a shift in balance occurring in favor of suppressed angiogenesis. Current therapeutic strategies to enhance wound-based angiogenesis, including topical applications of growth factors are inadequate and new treatment is needed especially when viewed in the context of increasing rates of obesity and diabetes during the recent years. To this end, we will describe the â??angiogenesis model of wound healingâ?�. Moreover, the cellular and molecular cascades that coordinate angiogenesis in healthy and diabetic wounds will be addressed. Finally, rather than providing an encyclopedia survey, we will focus on a recent discovery by our laboratory confirming a new molecular target (e.g., CREM/ICER-HIF-1-VEGF axis) that may have translational potential in providing therapeutic avenues, aimed at advancing the treatment of angiogenesis-dependent disorders including delayed wound healing. Recent Publications 1. Bitar, M.S. and F. Al-Mulla, Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1alpha-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes. Dis Model Mech, 2015. 8(1): p. 65-Falanga, V., Wound healing and its impairment in the diabetic foot. Lancet, 2005. 366(9498): p. 1736-43. 2. Swift, M.E., H.K. Kleinman, and L.A. DiPietro, Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest, 1999. 79(12): p. 1479-87. 3. Carmeliet, P. and R.K. Jain, Molecular mechanisms and clinical applications of angiogenesis. Nature 2011.473(7347): p. 298-307. 4. Folkman, J., Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov, 2007. 6(4): p.273-86. 5. Bitar, M.S., Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. Surgery, 2000. 127(6): p. 687-95.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Diabetic Complications & Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetic Complications & Medicine
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Milad S. Bitar”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels